510 results on '"Katial, Rohit"'
Search Results
2. Multivariate Cluster Analyses to Characterize Asthma Heterogeneity and Benralizumab Responsiveness
3. Approach to diagnosing and managing granulomatous-lymphocytic interstitial lung disease
4. Exploring Definitions and Predictors of Response to Biologics for Severe Asthma
5. Biologics in Asthma: Potential to Achieve Clinical Remission
6. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry
7. A Response to: Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”
8. Clinical Implications of Longitudinal Blood Eosinophil Counts in Patients With Severe Asthma
9. Comment on geographic variation in disease burden among patients with severe persistent asthma in the United States
10. Urticaria and Angioedema
11. Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab
12. Systemic Corticosteroid–related Adverse Outcomes and Health Care Resource Utilization and Costs Among Patients with Chronic Rhinosinusitis with Nasal Polyposis
13. Real-world effectiveness of benralizumab: Results from the ZEPHYR 1 Study
14. DUPILUMAB IMPROVES ASTHMA CONTROL AND REDUCES FRACTIONAL EXHALED NITRIC OXIDE AND EXACERBATIONS WITH INHALED CORTICOSTEROID WITHDRAWAL: A PHASE 2 STUDY.
15. Test Performance Characteristics of the AIR, GAD-7 and HADS-Anxiety Screening Questionnaires for Anxiety in Chronic Obstructive Pulmonary Disease
16. THE AUTHORS RESPOND
17. Eosinophilic Gastrointestinal Diseases
18. Impact of Patient Baseline Characteristics On Work Productivity and Activity Impairment Following Omalizumab Treatment In Patients With Allergic Asthma
19. Skin Test (ST) Responses to Seasonal and Perennial allergens in a Broad Asthma Population Across Severities and Comorbidities
20. CLINICAL EFFICACY OF DUPILUMAB TREATMENT DURING WITHDRAWAL OF INHALED CORTICOSTEROIDS/LONG-ACTING BETA AGONISTS
21. Benralizumab in Severe Eosinophilic Asthma and Chronic Rhinosinusitis with Nasal Polyps: The Real-World, Multi-Country RANS Observational Study
22. Treating moderate-to-severe atopic dermatitis with benralizumab: results from the HILLIER study, a plain language summary.
23. Allergen skin test responses in broad U.S. asthma population in those with and without rhinitis.
24. Safety of Reslizumab in Uncontrolled Asthma with Eosinophilia: A Pooled Analysis from 6 Trials
25. Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma
26. A cost comparison of benralizumab, mepolizumab, and dupilumab in patients with severe asthma: A US third-party payer perspective
27. Adult Asthma
28. Pulmonary Function Testing
29. The Pharmacotherapy of Rhinitis and Asthma
30. Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps
31. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
32. Bronchoprovocation Testing in Asthma: An Update
33. Exhaled Nitric Oxide: An Update
34. Benralizumab in Severe Eosinophilic Asthma and Chronic Rhinosinusitis with Nasal Polyps: The Real-World, Multi-Country RANS Observational Study.
35. PB2229: A PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF BENRALIZUMAB IN PATIENTS WITH HYPEREOSINOPHILIC SYNDROME
36. Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies
37. Asthma Yardstick: Practical recommendations for a sustained step-up in asthma therapy for poorly controlled asthma
38. Association Between Elevated Blood Eosinophils and Chronic Kidney Disease Progression: Analyses of a Large United States Electronic Health Records Database.
39. Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease
40. Effect of Baseline Blood Eosinophil Level on Asthma Exacerbations Among Patients Treated with Benralizumab During the Oral Corticosteroid Reduction Phase of the PONENTE Trial
41. A Phase 3 Study Evaluating The Efficacy And Safety Of Benralizumab In Patients With Hypereosinophilic Syndrome
42. Asthma Clinical Remission with Benralizumab in an Integrated Analysis of the Real-World XALOC-1 Study
43. Early Asthma Control Improvement with Benralizumab: 8-Week Interim Integrated Analysis from the Real-World XALOC-2 Study
44. Association Between Elevated Blood Eosinophils and Chronic Kidney Disease Progression: Analyses of a Large United States Electronic Health Records Database
45. Biologics in practice: A unique opportunity for allergist/immunologist expertise
46. Chronic Rhinosinusitis and Aspirin-Exacerbated Respiratory Disease
47. Nonsteroidal anti-inflammatory–induced inhibition of signal transducer and activator of transcription 6 (STAT-6) phosphorylation in aspirin-exacerbated respiratory disease
48. Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the Literature
49. Diseases in DDx of Asthma: Vocal Cord Dysfunction
50. Aspirin-Exacerbated Respiratory Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.